Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.https://www.creative-peptides.com/product/taspoglutide-item-10-101-176-33662.html
